HYBRID EVENT: You Can Participate In Person At Shanghai, China Or Virtually From Your Home Or Work
ICTOCCC · Registering as Listener

International Conference on Translational Oncology, Cardiology and Critical Care

1–2 Jun 2027 Shanghai, China Standard / Physical Participation
Listener Registration
$135
virtual · $175 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.
All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon code

Have a code? Apply it here — the discount updates the total immediately.
Apply

1. Policy on Cancellations & Refunds :

  • A full refund is possible only if the cancellation request is submitted at least 70 days before the conference, with formal paperwork completed at least 60 days prior.
  • If cancellation occurs between 60 and 30 days before the event, partial refunds may be granted based on administrative costs incurred.
  • Cancellations made within 30 days of the event are non-refundable, though participants will receive a credit valid for one year.
  • Registrations made less than 30 days before the event are not eligible for refunds, but may be transferred to another ISIT conference.
  • Since this conference is hybrid format, the organizer reserves the right to conduct the event either in-person or virtually. Please note that no refunds will be issued due to changes in the event format.
  • Virtual registration fees are non-refundable. A credit will instead be issued for use at a future conference event.

2. Participation & Registration Requirements :

  • To attend an ISIT event, participants must complete the registration process within the stipulated time.
  • The event schedule, venue, and format are subject to changes at the discretion of the organizers, with prior notice sent via email.
  • ISIT is not liable for any financial losses resulting from changes in event details.
  • Fees paid for registration are strictly non-refundable.
  • If the primary author cannot participate, a co-author may attend instead, but refunds will not be granted for non-attendance.

3. Submission & Publication Norms :

  • Researchers submitting papers to ISIT must ensure their institution or supervisor is aware of their submission.
  • Each submission is subject to a rigorous peer review before being accepted for presentation.
  • Only papers linked to a completed registration will be included in conference proceedings.
  • The submitting author is considered the primary author; ISIT does not verify individual authorship claims.
  • If any concerns regarding authorship arise and are validated, the paper will be withdrawn without reconsideration.
  • Once a paper is removed, it cannot be reintroduced into any ISIT publication.

4. Travel & Accommodation Responsibilities :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.

5. Visa & Invitation Letter Policy :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.
  • ISIT does not engage directly with consulates or embassies on behalf of attendees.
  • Participants must handle their own visa applications and processes.
  • Important Information Regarding Invitation Letters:
    • The invitation letter is provided solely for conference attendance and does not serve as a document for immigration, employment, or residency purposes.
    • The letter assists in visa applications but does not guarantee visa approval.
    • ISIT holds no responsibility for visa denials or processing delays, and all related costs are borne by the applicant.
    • Any alterations or unauthorized use of the invitation letter will result in its invalidation and possible cancellation of conference participation.
    • Legal action may be pursued if the document is misused.
    • By accepting the invitation letter, attendees agree to comply with international travel regulations and ethical participation standards.

6. Registration Transfers :

  • Registrations may be transferred to another individual from the same institution if the original participant cannot attend.
  • Transfer requests must be made via email to [email protected] with necessary details and supporting documents.
  • Transfers must be requested at least 14 days before the event; otherwise, they will not be accommodated.
  • Transferred registrations are not eligible for refunds.

7. General Considerations :

  • Any modifications or cancellations must be communicated in writing to [email protected].
  • Registration confirms acknowledgment and acceptance of these policies.
  • ISIT does not initiate automatic transactions; all payments are voluntarily completed by registrants.
  • Once registered, participants must submit a conference registration form within three days for confirmation.
  • Travel plans should only be finalized after receiving the official conference itinerary, which will be shared 15 days before the event.

8. Conference Programme and Participation Policy :

  • Presentations from different but relevant academic areas may be combined by the Organiser within an interdisciplinary or multidisciplinary programme to encourage cross-disciplinary understanding, interaction, and future research partnerships.
Payments encrypted & processed securely. Refundable up to 14 days before the event.

What you'll hear about

Session tracks covered across the event.
View all 11 tracks →
This track focuses on the latest breakthroughs in translational oncology, emphasizing the integration of laboratory research into clinical practice. Discussions will include novel therapeutic approaches and their implications for patient outcomes.
This session will explore cutting-edge research in cardiology, highlighting the transition of innovative findings from laboratory settings to clinical applications. Topics will include new diagnostic tools and treatment strategies for heart disease.
This track addresses the unique challenges faced in the critical care of oncology patients, focusing on patient management strategies and outcomes. Emphasis will be placed on multidisciplinary approaches to improve care in this vulnerable population.
This session will delve into the role of precision medicine in oncology, examining how genetic and molecular profiling can tailor treatments to individual patients. Participants will discuss the implications for clinical trials and patient management.
This track will explore the intersection of cardiology and oncology, focusing on the cardiovascular implications of cancer therapies. Discussions will include risk assessment, management strategies, and the importance of collaborative care.
This session will highlight recent advancements in intensive care practices, particularly in the context of oncology and cardiology. Emphasis will be placed on technology integration and evidence-based protocols to enhance patient safety and outcomes.
This track will examine acute care strategies in cardiology, focusing on the management of acute cardiac events. Participants will discuss best practices, clinical guidelines, and innovations that improve patient care.
This session will address the unique challenges faced in pediatric oncology, including treatment protocols and psychosocial considerations. Innovations in care delivery and research will be highlighted to improve outcomes for young patients.
This track will explore the impact of healthcare policy on patient safety within critical care settings. Discussions will include regulatory frameworks, quality improvement initiatives, and the role of multidisciplinary teams.
This session will focus on the role of integrative medicine in enhancing traditional oncology and cardiology treatments. Participants will discuss evidence-based complementary therapies and their impact on patient well-being.
This track will examine the landscape of clinical trials in oncology and cardiology, focusing on innovative trial designs and methodologies. Participants will discuss challenges faced in recruitment, retention, and data analysis.